Last updated on March 2018

A clinical trial seeking patients for a research study for the treatment of NIDDM

Brief description of study

This is a multi-center, randomised, double-blind, placebo-controlled, parallel-group, efficacy and safety study of empagliflozin as add-on to insulin in Japanese patients with Type 2 Diabetes Mellitus with insufficient glycaemic control

Clinical Study Identifier: NCT02589639

Contact Investigators or Research Sites near you

Start Over

Saiseikai Fukuoka General Hospital

Fukuoka, Fukuoka, Japan

Kunisaki Makoto Clinic

Fukuoka, Japan

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.